{"id":181384,"date":"2021-02-18T00:54:45","date_gmt":"2021-02-17T21:54:45","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/covid-19-associated-with-leukoencephalopathy-on-brain-mri\/"},"modified":"2021-02-18T00:54:45","modified_gmt":"2021-02-17T21:54:45","slug":"covid-19-associated-with-leukoencephalopathy-on-brain-mri","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/covid-19-associated-with-leukoencephalopathy-on-brain-mri\/","title":{"rendered":"#COVID-19 associated with leukoencephalopathy on brain MRI"},"content":{"rendered":"

“#COVID-19 associated with leukoencephalopathy on brain MRI<\/strong>”<\/p>\n

\n
\n
\n
\"mri\"
\n Credit: Pixabay\/CC0 Public Domain
\n <\/figcaption><\/figure>\n<\/div>\n<\/div>\n

According to an open-access article in ARRS’ American Journal of Roentgenology (AJR)<\/i>, COVID-19-related disseminated leukoencephalopathy (CRDL) represents an important\u2014albeit uncommon\u2014differential consideration in patients with neurologic manifestations of coronavirus disease (COVID-19).\n <\/p>\n

“Increasingly,” wrote Colbey W. Freeman and colleagues from the University of Pennsylvania, “effects of COVID-19 on the brain are being reported, including acute necrotizing encephalopathy, infarcts, microhemorrhage, acute disseminated encephalomyelitis, and leukoencephalopathy.”<\/p>\n

Among the 2,820 patients with COVID-19 admitted to the authors’ institution between March 1 and June 18, 2020, 59 (2.1%) underwent brain MRI. Three (5.1%) had known white matter lesions from multiple sclerosis, 23 (39.0%) had white matter lesions of small vessel ischemic disease, six (10.2%) had acute infarcts, four (6.8%) had subacute infarcts, four (6.8%) had chronic infarcts, one (1.7%) had abnormal basal ganglia signal from hypoxemia, two (3.4%) had microhemorrhage in association with chronic infarcts, and two (3.4%) had microhemorrhage associated with acute or subacute infarcts.<\/p>\n

Six patients (10.2%; four women, two men; age range, 41-86 years) had neuroimaging findings suggestive of CRDL\u2014”characterized by extensive confluent or multifocal white matter lesions (with characteristics and locations atypical for other causes), microhemorrhages, diffusion restriction, and enhancement,” Freeman et al. explained. Hypertension (4\/6, 66.7%) and type 2 diabetes mellitus (3\/6, 50.0%) were common comorbidities.<\/p>\n

Reiterating that no established criteria exist for defining CRDL, “our patients had white matter lesions atypical for other causes,” as well as “involvement of the bilateral middle cerebellar peduncles and corpus callosum,” the authors of this AJR article concluded.\n <\/p>\n\n

\n

Multi-institutional study looks at brain MRI findings in COVID-19\n <\/p><\/div>\n

\n
\n More information:<\/strong>
\n Colbey W. Freeman et al, Coronavirus Disease (COVID-19)-Related Disseminated Leukoencephalopathy: A Retrospective Study of Findings on Brain MRI, American Journal of Roentgenology<\/i> (2020). DOI: 10.2214\/AJR.20.24364<\/a><\/p><\/div>\n
\n Provided by
\n American Roentgen Ray Society
\n
\n <\/svg><\/a><\/p><\/div>\n

<\/p>\n

\n

\n Citation<\/strong>:
\n COVID-19 associated with leukoencephalopathy on brain MRI (2021, February 17)
\n retrieved 18 February 2021
\n from https:\/\/medicalxpress.com\/news<\/a>\/2021-02-covid-leukoencephalopathy-brain-mri.html<\/p>\n

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
\n part may be reproduced without the written permission. The content is provided for information purposes only.<\/p><\/div>\n<\/p><\/div>\n